Effects of growth hormone and insulin-like growth factor-1 on hepatocyte antioxidative enzymes

被引:89
|
作者
Brown-Borg, HM [1 ]
Rakoczy, SG [1 ]
Romanick, MA [1 ]
Kennedy, MA [1 ]
机构
[1] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA
关键词
hormones; aging; growth factors; catalase; glutathione peroxidase;
D O I
10.1177/153537020222700203
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The physiological decline that occurs in aging is thought to result, in part, from accumulation of oxidative damage generated by reactive oxygen species during normal metabolic processes. Elevated levels of antioxidative enzymes in liver tissues are present in the Ames dwarf, a growth hormone (GH)-deficient mouse that lives more than I year longer than wild-type mice from the same line. In contrast, transgenic mice that overexpress GH exhibit depressed hepatic levels of catalase and have significantly shortened life spans. In this study, we evaluated the in vitro effects of GH and insulin-like growth factor 1 (IGF-1) on antioxidative enzymes in mouse hepatocytes. Hepatocytes were isolated from wild-type mice following perfusion of livers with a collagenase-based buffer. Dispersed cells were plated on Matrigel and treated with rat GH (0.1, 1.0, or 10 mug/ml) or IGF-1 (0.5, 5.0, or 50 nM) for 24 hr. Hepatocytes were recovered and protein was extracted for immunoblotting and enzyme activity assays of catalase (CAT), glutathione peroxidase (GPX), and manganese superoxide dismutase (MnSOD). A 41% and 27% decrease in catalase activity was detected in cells treated with GH, whereas IGF-1 reduced CAT activity levels to a greater extent than GH (P < 0.0001). The activity and protein levels of GPX were also significantly depressed in cells treated with GH, whereas activity alone was decreased in cells treated with IGF-1 (P < 0.04). GH significantly suppressed MnSOD levels by 40% and 66% in 1.0 and 0.1 mug/ml concentrations, respectively. Similarly, IGF-1 decreased MnSOD protein levels (5 nM; P < 0.05). These results suggest that GH and IGF-1 may decrease the ability of hepatocytes to counter oxidative stress. In addition, these experiments provide an explanation for the differing antioxidative defense capacity of GH-deficient versus GH-over-expressing mice, and they suggest that GH is directly involved in antioxidant regulation and the aging process.
引用
收藏
页码:94 / 104
页数:11
相关论文
共 50 条
  • [41] Influence of insulin-like growth factor-1 and hepatocyte growth factor on carotid atherosclerosis and cognitive function in the elderly
    Watanabe, T
    Yamamoto, H
    Idei, T
    Iguchi, T
    Katagiri, T
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 18 (01) : 67 - 74
  • [42] Relationship of growth hormone and insulin-like growth factor-1 genotypes with growth and carcass traits in swine
    CasasCarrillo, E
    PrillAdams, A
    Price, SG
    Clutter, AC
    Kirkpatrick, BW
    ANIMAL GENETICS, 1997, 28 (02) : 88 - 93
  • [43] Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat
    Duerr, RL
    McKirnan, MD
    Gim, RD
    Clark, RG
    Chien, KR
    Ross, J
    CIRCULATION, 1996, 93 (12) : 2188 - 2196
  • [44] The effects of growth hormone and insulin-like growth factor-1 on the aging cardiovascular system and its progenitor cells
    Devin, Jessica K.
    Young, Pampee P.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (09) : 983 - 992
  • [45] Effects of chronic growth hormone/insulin-like growth factor-1 deficiency on osteoarthritis in rat knee joints
    Ekenstedt, KJ
    Sonntag, WE
    Loeser, RF
    Lindgren, BR
    Carlson, CS
    OSTEOARTHRITIS AND CARTILAGE, 2004, 12 : S7 - S8
  • [46] Acute Effects of Blood Transfusion on Growth Hormone and Insulin-Like Growth Factor-1 Levels in Children with Thalassemia
    Mahachoklertwattana, Pat
    Yimsumruay, Titiya
    Poomthavorn, Preamrudee
    Chuansumrit, Ampaiwan
    Khlairit, Patcharin
    HORMONE RESEARCH IN PAEDIATRICS, 2011, 75 (04): : 240 - 245
  • [47] The Somatotrope Growth Hormone-Releasing Hormone/Growth Hormone/Insulin-Like Growth Factor-1 Axis in Immunoregulation and Immunosenescence
    Bodart, Gwennaelle
    Farhat, Khalil
    Charlet-Renard, Chantal
    Salvatori, Roberto
    Geenen, Vincent
    Martens, Henri
    ENDOCRINE IMMUNOLOGY, 2017, 48 : 147 - 159
  • [48] SHOX Gene Variants: Growth Hormone/Insulin-Like Growth Factor-1 Status and Response to Growth Hormone Treatment
    Shapiro, Sofia
    Klein, Genna W.
    Klein, Michelle L.
    Wallach, Elizabeth J.
    Fen, Ye
    Godbold, James H.
    Rapaport, Robert
    HORMONE RESEARCH IN PAEDIATRICS, 2015, 83 (01): : 26 - 35
  • [49] Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases
    Denko, CW
    Malemud, CJ
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 35 (01) : 24 - 34
  • [50] The aging brain: is function dependent on growth hormone/insulin-like growth factor-1 signaling?
    B. A. Forshee
    AGE, 2006, 28 : 173 - 180